185 related articles for article (PubMed ID: 22622203)
1. Transoral incisionless fundoplication with EsophyX® for treatment of gastro-oesphageal reflux disease.
Testoni PA; Vailati C
Dig Liver Dis; 2012 Aug; 44(8):631-5. PubMed ID: 22622203
[TBL] [Abstract][Full Text] [Related]
2. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations.
Bell RC; Cadière GB
Surg Endosc; 2011 Jul; 25(7):2387-99. PubMed ID: 21184101
[TBL] [Abstract][Full Text] [Related]
3. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy.
Stefanidis G; Viazis N; Kotsikoros N; Tsoukalas N; Lala E; Theocharis L; Fassaris A; Manolakopoulos S
Dis Esophagus; 2017 Feb; 30(3):1-8. PubMed ID: 27868281
[TBL] [Abstract][Full Text] [Related]
4. Reflux parameters as modified by EsophyX or laparoscopic fundoplication in refractory GERD.
Frazzoni M; Conigliaro R; Manta R; Melotti G
Aliment Pharmacol Ther; 2011 Jul; 34(1):67-75. PubMed ID: 21539587
[TBL] [Abstract][Full Text] [Related]
5. Antireflux transoral incisionless fundoplication using EsophyX: 12-month results of a prospective multicenter study.
Cadière GB; Buset M; Muls V; Rajan A; Rösch T; Eckardt AJ; Weerts J; Bastens B; Costamagna G; Marchese M; Louis H; Mana F; Sermon F; Gawlicka AK; Daniel MA; Devière J
World J Surg; 2008 Aug; 32(8):1676-88. PubMed ID: 18443855
[TBL] [Abstract][Full Text] [Related]
6. Transoral incisionless fundoplication for gastro-esophageal reflux disease: Techniques and outcomes.
Testoni PA; Mazzoleni G; Testoni SG
World J Gastrointest Pharmacol Ther; 2016 May; 7(2):179-89. PubMed ID: 27158533
[TBL] [Abstract][Full Text] [Related]
7. Transoral incisionless fundoplication for the treatment of gastroesophageal reflux disease.
Reavis KM; Perry KA
Expert Rev Med Devices; 2014 Jul; 11(4):341-50. PubMed ID: 24918903
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Outcomes of Transoral Incisionless Fundoplication in a High-Risk Pediatric Population.
Robertson JO; Jarboe MD
J Laparoendosc Adv Surg Tech A; 2018 Jan; 28(1):95-100. PubMed ID: 29049004
[TBL] [Abstract][Full Text] [Related]
9. Esophagopulmonary fistula and left lung abscess after transoral incisionless fundoplication.
Titus JM; Mason DP; Raymond DP; Rice TW; Murthy SC
Ann Thorac Surg; 2013 Aug; 96(2):689-91. PubMed ID: 23910114
[TBL] [Abstract][Full Text] [Related]
10. Endoluminal fundoplication (ELF)--evolution of EsophyX, a new surgical device for transoral surgery.
Cadière GB; Rajan A; Rqibate M; Germay O; Dapri G; Himpens J; Gawlicka AK
Minim Invasive Ther Allied Technol; 2006; 15(6):348-55. PubMed ID: 17190659
[TBL] [Abstract][Full Text] [Related]
11. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.
Jobe BA; O'Rourke RW; McMahon BP; Gravesen F; Lorenzo C; Hunter JG; Bronner M; Kraemer SJ
Ann Surg; 2008 Jul; 248(1):69-76. PubMed ID: 18580209
[TBL] [Abstract][Full Text] [Related]
12. Transoral Incisionless Fundoplication TIF 2.0 with "EsophyX Z®" Device for GERD: Seven Years after Endo Lumenal Fundoplication. World’s First Case Report.
Nicolau AE; Lobonţiu A
Chirurgia (Bucur); 2018; 113(6):849-856. PubMed ID: 30596372
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study.
Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S
Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical trial: transoral incisionless fundoplication vs. sham intervention to control chronic GERD.
Håkansson B; Montgomery M; Cadiere GB; Rajan A; Bruley des Varannes S; Lerhun M; Coron E; Tack J; Bischops R; Thorell A; Arnelo U; Lundell L
Aliment Pharmacol Ther; 2015 Dec; 42(11-12):1261-70. PubMed ID: 26463242
[TBL] [Abstract][Full Text] [Related]
15. Advances in transoral fundoplication for oesophageal reflux.
Zagol B; Mikami D
Dig Liver Dis; 2011 May; 43(5):361-4. PubMed ID: 21382755
[TBL] [Abstract][Full Text] [Related]
16. Three-year results of a multicenter prospective study of transoral incisionless fundoplication.
Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G
Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006
[TBL] [Abstract][Full Text] [Related]
17. Transoral incisionless fundoplication (TIF 2.0) with EsophyX for gastroesophageal reflux disease: long-term results and findings affecting outcome.
Testoni PA; Vailati C; Testoni S; Corsetti M
Surg Endosc; 2012 May; 26(5):1425-35. PubMed ID: 22170317
[TBL] [Abstract][Full Text] [Related]
18. Transoral incisionless fundoplication for gastroesophageal reflux disease in an unselected patient population.
Demyttenaere SV; Bergman S; Pham T; Anderson J; Dettorre R; Melvin WS; Mikami DJ
Surg Endosc; 2010 Apr; 24(4):854-8. PubMed ID: 19730949
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic Hiatal Hernia Repair With Concomitant Transoral Incisionless Fundoplication.
Pype DL
AORN J; 2023 Mar; 117(3):149-158. PubMed ID: 36825913
[TBL] [Abstract][Full Text] [Related]
20. Transoral incisionless fundoplication for treatment of refractory GERD after peroral endoscopic myotomy.
Kumta NA; Kedia P; Sethi A; Kahaleh M
Gastrointest Endosc; 2015 Jan; 81(1):224-5. PubMed ID: 25016405
[No Abstract] [Full Text] [Related]
[Next] [New Search]
